|
Post by myocat on May 30, 2017 15:20:49 GMT -5
Can't view the link.
|
|
|
Post by kc on May 30, 2017 15:23:26 GMT -5
My bad... It is an requesting an extension of a previous grant of confidential treatment
www.sec.gov/Archives/edgar/data/318154/999999999717006565/filename1.pdf
Amgen Inc. File No. 0-12477 - CF#35032 _____________________ Amgen Inc. submitted an application under Rule 24b-2 requesting an extension of a previous grant of confidential treatment for information it excluded from the Exhibits to a Form 10-Q filed on May 8, 2012 and Form 10-K filed on February 19, 2015. Based on representations by Amgen Inc. that this information qualifies as confidential trade secrets, commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibit(s) will not be released to the public for the time period(s) specified: Exhibit to Form Filed on Confidential Treatment Granted 10.37 10-K February 19, 2015 through May 8, 2022 10.55 10-Q May 8, 2012 through May 8, 2022 For the Commission, by the Division of Corporation Finance, pursuant
Mod's please delete this thread.
|
|
|
Post by mnkdorbust on May 30, 2017 15:23:40 GMT -5
If you copy and paste the link it works. Or click on the link then remove the %C2%A0 after the .htm
|
|